Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
mRS and INCAT score evolution from baseline to mid-term visit ( * P
Forest plot showing the improvement of INCAT score of CIDP patients ...
Number of responders by the adjusted INCAT score at completion (ITT ...
SUPPLEMENT 4 - Modified INCAT Sensory Sum Score (mISS) - Fill and Sign ...
Mean MRC sum score, INCAT sensory sum score and ODSS at baseline and ...
Response rate by INCAT and MRC sum score in PRIMA and PATH | Download Table
INCAT Score | PDF
The proportion of improvement and improved INCAT and cI-RODS score of ...
Getting closer to patients: the INCAT Overall Disability Sum Score ...
INCAT score | PDF
About CIDP: using the INCAT scale to measure signs and symptoms
Mean change from baseline in INCAT total score, grip strength, and MRC ...
Mean adjusted Inflammatory Neuropathy Cause and Treatment (INCAT) score ...
Time to improvement of 51 point in adjusted INCAT score. Data by ...
Clinical characteristics from CIDP patients with INCAT disability ...
Correlation of INCAT with NK cells and their markers | Download ...
INCAT Disability Scale for CIDP Assessment | PDF
Mean scores of clinical outcome variables (± SD), INCAT (A), Hugues ...
Percentage of observed subjects with stable/improved or worsening INCAT ...
Spotlight on Chronic Inflammatory Demyelinating Polyradiculoneuropathy ...
Challenges in Diagnosis and Treatment of CIDP: Perspectives | TCRM
(PDF) Efficacy and safety of Privigen® in patients with chronic ...
(PDF) Chronic inflammatory demyelinating polyneuropathy (CIDP): Change ...
Longer-term effects of intravenous immunoglobulin treatment in chronic ...
Intravenous immunoglobulin for maintenance treatment of chronic ...
Chronic Inflammatory Demyelinating Polyneuropathy - Practical Neurology
Table 1 from Psychometric evaluation of a new sensory scale in immune ...
Extracorporeal therapy procedures (plasma exchange and immunoadsorption ...
The effect of tremor on disability assessment in chronic inflammatory ...
Efficacy and safety of Privigen(®) in patients with chronic ...
Frontiers | Beneficial effects and safety of traditional Chinese ...
(PDF) Quantitative grip force assessment of muscular weakness in ...
Treatment of chronic inflammatory demyelinating polyneuropathy | PPTX
Chronic Inflammatory Demyelinating Polyneuropathy: Considerations for ...
(PDF) Inflammatory Neuropathy Cause and Treatment (INCAT) Scale for the ...
Safety and Tolerability of Immune Globulin Intravenous in Chronic ...
A prospective real-world study of efgartigimod in the treatment of ...
Clinical scoring systems in Chronic Inflammatory Demyelinating ...
Determinants of long‐term disability in chronic inflammatory ...
Motor impairment. (A) 1–7: Chronic inflammatory demyelinating ...
A real-world study of tacrolimus in maintenance treatment of CIDP | ITT
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory ...
In persons with CIDP, AUTO-HSCT can be conducted fully on an outpatient ...
INCAT-ODSS before and after first (n = 48), second (n = 18), and third ...
Cidp 症例報告, Cidp 治療 ガイドライン , 慢性炎症性脱髄性多発根ニューロパチー CIDP – NNTT
(PDF) Hematopoietic stem cell transplantation for chronic inflammatory ...
Analysis of relapse by inflammatory Rasch‐built overall disability ...
ADHERE clinical trial data: see efficacy results for VYVGART Hytrulo
Clinical course. All patients (n=21) were examined at baseline and ...
(PDF) Analysis of Relapse by Inflammatory Rasch‐built Overall ...
Clinical scores. Time 1: pre-SCIg; time 2: during SCIg; MRC: Medical ...
Response to treatment based on adjusted Inflammatory Neuropathy Cause ...
Subgroup analyses of mild and higher function disability | Download ...
Systemic terminal complement activation correlates with disease ...
Privigen Mechanism of Action | MIMS Malaysia
Clinical stability after switch from IVIg to SCIg (IgPro20). Clinical ...
Pin on Information/Instructions
GAMMAKED™ Treatment for CIDP: MOA and Symptom Understanding
Assessment of INCAT, ISS, and MRC Scales Before and After Treatment ...
